ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 232 filers reported holding ARGENX SE in Q2 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,130,749 | +61.2% | 2,300 | +27.8% | 0.00% | +100.0% |
| Q2 2023 | $701,514 | -14.4% | 1,800 | -18.2% | 0.00% | 0.0% |
| Q1 2023 | $819,676 | -92.4% | 2,200 | -92.3% | 0.00% | -90.0% |
| Q2 2022 | $10,811,000 | +66.9% | 28,535 | +38.9% | 0.01% | +100.0% |
| Q1 2022 | $6,479,000 | -17.3% | 20,550 | -8.0% | 0.01% | 0.0% |
| Q4 2021 | $7,835,000 | +1.0% | 22,340 | -13.0% | 0.01% | -16.7% |
| Q3 2021 | $7,756,000 | +98.4% | 25,680 | +97.8% | 0.01% | +100.0% |
| Q2 2021 | $3,910,000 | -10.5% | 12,985 | -18.1% | 0.00% | -25.0% |
| Q1 2021 | $4,367,000 | +17.8% | 15,855 | +25.8% | 0.00% | 0.0% |
| Q4 2020 | $3,707,000 | +160.3% | 12,605 | +132.4% | 0.00% | +100.0% |
| Q3 2020 | $1,424,000 | +16.5% | 5,425 | 0.0% | 0.00% | +100.0% |
| Q2 2020 | $1,222,000 | +119.8% | 5,425 | +28.6% | 0.00% | 0.0% |
| Q1 2020 | $556,000 | -84.0% | 4,220 | -80.5% | 0.00% | -66.7% |
| Q4 2019 | $3,482,000 | +77.7% | 21,690 | +25.9% | 0.00% | +50.0% |
| Q3 2019 | $1,960,000 | -20.6% | 17,230 | -1.2% | 0.00% | 0.0% |
| Q2 2019 | $2,470,000 | +9.6% | 17,440 | -3.4% | 0.00% | 0.0% |
| Q1 2019 | $2,253,000 | +36.4% | 18,050 | +5.2% | 0.00% | 0.0% |
| Q4 2018 | $1,652,000 | – | 17,155 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 297,701 | $112,778,070 | 70.21% |
| Artia Global Partners LP | 85,204 | $32,277,831 | 12.30% |
| Avoro Capital Advisors LLC | 1,265,555 | $479,430,201 | 7.16% |
| DCF Advisers, LLC | 25,000 | $9,470,750 | 6.40% |
| Eagle Health Investments LP | 60,300 | $22,843,449 | 5.27% |
| Avidity Partners Management LP | 625,000 | $236,768,750 | 5.13% |
| Bellevue Group AG | 911,100 | $345,152,013 | 4.58% |
| Fairmount Funds Management LLC | 73,526 | $27,853,855 | 4.42% |
| Paradigm Biocapital Advisors LP | 89,556 | $33,926,499 | 3.98% |
| RTW INVESTMENTS, LP | 482,195 | $182,669,932 | 3.73% |